⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL61064 | 1.00 | — | — | |
| SCHEMBL887143 | 1.00 | — | — | |
| SCHEMBL1509733 | 0.88 | ALOX15 (0.43) | — | |
| SCHEMBL52133 | 0.80 | — | — | |
| SCHEMBL756717 | 0.80 | — | — | |
| Ammonia Solution, Strong SCHEMBL28439739 | 0.78 | CYP2D6 (0.61) | — | |
| SCHEMBL9069778 | 0.78 | — | — | |
| SCHEMBL2744870 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL21820004 | 0.78 | CYP2D6 (0.61) | — | |
| SCHEMBL285407 | 0.75 | CYP2D6 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 17143 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024105092-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATING OR PREVENTING TRANSTHYRETIN-MEDIATED AMYLOIDOSIS | NEURIMMUNE AG (CH) | 2024-05-23 | — | — | WO | claimed |
| WO-2024105062-A1 | METHODS FOR TREATING OR PREVENTING TRANSTHYRETIN-MEDIATED AMYLOIDOSIS | NEURIMMUNE AG (CH) | 2024-05-23 | — | — | WO | claimed |
| WO-2024042250-A1 | PHARMACEUTICAL FORMULATION AND DOSING REGIMEN FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | AL-S PHARMA AG (CH) | 2024-02-29 | — | — | WO | claimed |
| WO-2024020517-A1 | 3-(6-PYRIDIN-3-YL)-2-[4-(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)PIPERIDIN-1-YL]BENZONITRILE DERIVATIVES AND SIMILAR COMPOUNDS AS QPCTL AND QPCT INHIBITORS FOR THE TREATMENT OF CANCER | 858 THERAPEUTICS, INC. (US) | 2024-01-25 | — | — | WO | claimed |
| WO-2023205173-A1 | SUBSTITUTED PIPERIDINES AND SUBSTITUTED TETRAHYDROPYRIDINES AS IMMUNE-MODULATING COMPOUNDS | BLACKSMITH MEDICINES, INC. (US) | 2023-10-26 | — | — | WO | claimed |
| CN-115645543-A | Maytansinoid derivatives, conjugates thereof, and methods of use | 里珍纳龙药品有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-114822688-A | Prognostic analysis method based on primary liver cancer gene classification and liver cancer tissue energy metabolism | 浙江大学医学院附属第一医院 | 2022-07-29 | — | — | CN | claimed |
| US-20220175872-A1 | THERMOGENIC COMPOSITIONS AND METHODS | OHIO STATE INNOVATION FOUNDATION | 2022-06-09 | — | — | US | claimed |
| WO-2022071436-A1 | METHOD FOR MEASURING RNA CAPABLE OF DETECTING BIOLOGICAL AND PHYSIOLOGICAL PROCESSES | 国立研究開発法人医薬基盤・健康・栄養研究所 | 2022-04-07 | — | — | WO | claimed |
| US-20210138117-A1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2021-05-13 | — | — | US | claimed |
| WO-1981002576-A1 | NEW DERIVATIVES OF 1'0ALPHA,0ALPHA'-TREHALOSE AND DRUGS CONTAINING THEM | ANVAR (FR) | 1981-09-17 | — | — | WO | claimed |
| US-4278681-A | N-/6-//ACYLAMINOACYLAMINO OR AMINOACYLAMINO/PHENYL/-1,2-DIHYDRO-2-OXONICOTINYL/PENICILLINS | WARNER-LAMBERT CO. (US) | 1981-07-14 | — | — | US | claimed |
| EP-0015773-A2 | N-(6-((acylaminoacylamino or aminoacylamino)phenyl) 1,2-dihydro-2-oxonicotinyl)penicillin compounds, processes for their production and compositions containing them | WARNER-LAMBERT COMPANY (US) | 1980-09-17 | — | — | EP | claimed |
| EP-0015772-A1 | N-(2-((acylaminoacylamino or aminoacylamino)phenyl)-4-hydroxy-5-pyrimidinylcarbonyl)cephalosporin compounds, processes for their production, and compositions containing the same | WARNER-LAMBERT COMPANY (US) | 1980-09-17 | — | — | EP | claimed |
| EP-0015771-A1 | N-(6-((acylaminoacylamino or aminoacylamino)phenyl)-1,2-dihydro-2-oxonicotinyl) cephalosporin compounds, processes for their production, and compositions containing the same | WARNER-LAMBERT COMPANY (US) | 1980-09-17 | — | — | EP | claimed |
| US-4187298-A | MOTHPROOFING AGENTS, PICKLING INHIBITORS | ABBOTT LABORATORIES (US) | 1980-02-05 | — | — | US | claimed |
| EP-0006068-A2 | Compounds of the muramyl-peptide type and medicines containing them | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1979-12-12 | — | — | EP | claimed |
| EP-0004512-A1 | Muramyl-peptide ester derivatives and their application to pharmacological compositions and laboratory reactants | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1979-10-03 | — | — | EP | claimed |
| US-4082735-A | NOVEL IMMUNOLOGICAL ADJUVANT COMPOUNDS AND METHODS OF PREPARATION THEREOF | SYNTEX (U.S.A.) INC. (US) | 1978-04-04 | — | — | US | claimed |
| US-3956260-A | ANTIINFLAMMATORY | CIBA-GEIGY CORPORATION (US) | 1976-05-11 | — | — | US | claimed |